Rapidly Progressive Glomerulonephritis: A Single-Center Experience

OBJECTIVE: Rapidly progressive glomerulonephritis is associated with rapid deterioration of kidney function. We aimed to evaluate patients followed-up with the diagnosis of rapidly progressive glomerulonephritis. MATERIAL and METHODS: This retrospective study included 28 patients who were compared for remission status and baseline serum creatinine levels. RESULTS: We evaluated 20 male and 8 female patients with a mean age of 46.68 ±15.94 years. Patients with higher baseline serum creatinine had significantly lower hemoglobin (p=0.01), platelet counts (p=0.01) and calculated eGFR at last hospital visit (p=0.03) compared to patients with lower baseline serum creatinine. At discharge, the number of dialysis-dependent patients was significantly higher in the patients with higher baseline serum creatinine than the patients with lower baseline serum creatinine (p=0.01). Patients who had achieved remission had significantly lower percentage of cellular crescents (p= 0.009) and sclerotic glomeruli (p= 0.04) than patients who did not achieve remission. Dead patients were more likely to have a lymphocyte count of < 1000 cells/mm3 (p=0.009). CONCLUSION: Patients with high baseline serum creatinine levels were more likely to have lower hemoglobin levels and platelet counts. High baseline serum creatinine level and high percentage of cellular crescents and sclerotic glomeruli were related to worse renal prognosis. Patients with lower lymphocyte counts had higher mortality rates.

[1]  S. El-Sayegh,et al.  Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.

[2]  N. Ozkayar,et al.  Prognostic factors in crescentic glomerulonephritis: a single-center experience. , 2015, Iranian journal of kidney diseases.

[3]  R. Singh,et al.  Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[4]  C. Stegeman,et al.  Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[5]  Ľ. Podracká,et al.  [Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)]. , 2013, Vnitrni lekarstvi.

[6]  L. Harper,et al.  Complications of long-term therapy for ANCA-associated systemic vasculitis , 2012, Nature Reviews Nephrology.

[7]  H. Rupprecht,et al.  ANCA-associated vasculitis with renal involvement: an outcome analysis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  C. Zeng,et al.  Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. , 2003, Chinese medical journal.

[9]  R. Westendorp,et al.  Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.

[10]  L. Guillevin,et al.  Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. , 2001, Rheumatology.

[11]  C. Kallenberg,et al.  Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. , 1998, Journal of the American Society of Nephrology : JASN.

[12]  R. Falk,et al.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.

[13]  E. Ritz,et al.  Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. , 1991, Nephron.

[14]  R. Falk,et al.  Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  J. Velosa,et al.  Risk factors in idiopathic renal vasculitis and glomerulonephritis. , 1989, Kidney international.

[16]  W. Couser Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.